Ana L. Monteros-Los

Av Cuauhtemoc 330, CP 06720
Doctores, DIF 06720, Mexico

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 12 publications

The kinome, cyclins and cyclin-dependent kinases of pituitary adenomas, a look into the gene expression profile among tumors from different lineages.

The kinome, cyclins and cyclin-dependent kinases of pituitary adenomas, a look into the gene expression profile among tumors from different lineages.

Journal: BMC medical genomics

Published: September 10, 2021

Proteomic and Transcriptomic Analysis Identify Spliceosome as a Significant Component of the Molecular Machinery in the Pituitary Tumors Derived from POU1F1- and NR5A1-Cell Lineages.

Proteomic and Transcriptomic Analysis Identify Spliceosome as a Significant Component of the Molecular Machinery in the Pituitary Tumors Derived from POU1F1- and NR5A1-Cell Lineages.

Journal: Genes

Published: October 30, 2020

Clinical Heterogeneity of Ectopic ACTH Syndrome: A Long-Term Follow-Up Study.

Clinical Heterogeneity of Ectopic ACTH Syndrome: A Long-Term Follow-Up Study.

Journal: Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists

Published: June 05, 2020

From ACTH-Dependent to ACTH-Independent Cushing's Syndrome from a Malignant Mixed Corticomedullary Adrenal Tumor: Potential Role of Embryonic Stem Cells.

From ACTH-Dependent to ACTH-Independent Cushing's Syndrome from a Malignant Mixed Corticomedullary Adrenal Tumor: Potential Role of Embryonic Stem Cells.

Journal: Case reports in endocrinology

Published: December 20, 2019

Prevalence, Clinical and Biochemical Spectrum, and Treatment Outcome of Acromegaly With Normal Basal GH at Diagnosis.

Prevalence, Clinical and Biochemical Spectrum, and Treatment Outcome of Acromegaly With Normal Basal GH at Diagnosis.

Journal: The Journal of clinical endocrinology and metabolism

Published: May 22, 2018

LONG-TERM OUTCOME OF THE DIFFERENT TREATMENT ALTERNATIVES FOR RECURRENT AND PERSISTENT CUSHING DISEASE.

LONG-TERM OUTCOME OF THE DIFFERENT TREATMENT ALTERNATIVES FOR RECURRENT AND PERSISTENT CUSHING DISEASE.

Journal: Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists

Published: March 24, 2017

AIP mutations in young patients with acromegaly and the Tampico Giant: the Mexican experience.

AIP mutations in young patients with acromegaly and the Tampico Giant: the Mexican experience.

Journal: Endocrine

Published: January 28, 2016

Octreotide LAR treatment of acromegaly in "real life": long-term outcome at a tertiary care center.

Octreotide LAR treatment of acromegaly in "real life": long-term outcome at a tertiary care center.

Journal: Pituitary

Published: May 01, 2014

The role of primary pharmacological therapy in acromegaly.

The role of primary pharmacological therapy in acromegaly.

Journal: Pituitary

Published: October 30, 2013

Patient-focussed outcomes in acromegaly.

Patient-focussed outcomes in acromegaly.

Journal: Pituitary

Published: September 21, 2013

Persistence of Cushing's disease symptoms and comorbidities after surgical cure: a long-term, integral evaluation.

Persistence of Cushing's disease symptoms and comorbidities after surgical cure: a long-term, integral evaluation.

Journal: Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists

Published: April 02, 2013

Discontinuation of octreotide LAR after long term, successful treatment of patients with acromegaly: is it worth trying?

Discontinuation of octreotide LAR after long term, successful treatment of patients with acromegaly: is it worth trying?

Journal: European journal of endocrinology

Published: October 14, 2011

Showing 1-12 of 12

Last Updated: 09/26/2026